Demonstrated proof-of-concept for the dual agonist approach Phase 1b/2a (SC): Up to 24% weight loss at 36 weeks with doses up to 60 mg
Lipotropic injections are generally well-tolerated, but possible side effects include allergic reactions, gastrointestinal issues, and mild pain or irritation at the injection site
When mitochondria fail, the body cannot generate enough energy to meet even basic metabolic demands, directly causing the severe physical exhaustion and post-exertional malaise (PEM) that leaves patients bedbound after minor exertion
Injection Therapy Begins: Treatment involves quick, weekly injections administered according to your customized plan
Disclaimer: TRAVA is not affiliated with Metformin, Mounjaro, Ozempic, Rybelsus, Saxenda, Trulicity, Wegovy, or Zepbound
Stroet, M